Case report shows significant clinical improvement with GM-CSF in a woman with mucormycosis, suggesting its therapeutic potential.
This report outlines the case of a woman with rhino-orbital-cerebral mucormycosis following diabetic ketoacidosis, refractory to systemic and local antifungal treatment as well as repeated extensive sinonasal debridement. Adjunctive Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) therapy was associated with significant clinical improvement. This treatment restored visual acuity, and the excellent outcomes were maintained at the 24-month follow-up. This is the first report of successful use of a short course (5 days) of GM-CSF for refractory rhino-orbital cerebral mucormycosis in an adult patient after diabetic ketoacidosis, highlighting the therapeutic potential of this pragmatic approach.
No takes yet. Share an insight, caveat, or question.
Thayanantham et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: